Growth Metrics

Collegium Pharmaceutical (COLL) Short term Debt (2016 - 2025)

Collegium Pharmaceutical (COLL) has 10 years of Short term Debt data on record, last reported at $64.6 million in Q3 2025.

  • For Q3 2025, Short term Debt rose 123.04% year-over-year to $64.6 million; the TTM value through Sep 2025 reached $64.6 million, up 123.04%, while the annual FY2024 figure was $29.0 million, 84.21% down from the prior year.
  • Short term Debt reached $64.6 million in Q3 2025 per COLL's latest filing, roughly flat from $64.6 million in the prior quarter.
  • Across five years, Short term Debt topped out at $183.3 million in Q1 2023 and bottomed at $29.0 million in Q3 2024.
  • Average Short term Debt over 5 years is $108.9 million, with a median of $100.0 million recorded in 2022.
  • Peak YoY movement for Short term Debt: surged 236.07% in 2022, then crashed 84.21% in 2024.
  • A 5-year view of Short term Debt shows it stood at $48.4 million in 2021, then soared by 236.07% to $162.5 million in 2022, then increased by 12.82% to $183.3 million in 2023, then plummeted by 84.21% to $29.0 million in 2024, then soared by 123.04% to $64.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Short term Debt were $64.6 million in Q3 2025, $64.6 million in Q2 2025, and $64.6 million in Q1 2025.